Choose your country to see the products for your location

SALSA MLPA Probemix P496 KMT2A

Acute Myeloid Leukemia (AML) and other hematological malignancies

Region: KMT2A, chr. 5, 7, 11 and 17

MLPA | New
General information
The SALSA MLPA Probemix P496 KMT2A is a research use only (RUO) assay for the detection of deletions or duplications in the KMT2A gene. This probemix can also be used to detect the presence of the ASXL1 c.1934dupG mutation.

The histone methyltransferase KMT2A methylates lysine 3 on histone 4 (H3K4), thereby shaping the epigenetic landscape in cells, modulating chromatin accessibility and transcription. A subset of leukemias is characterised by KMT2A alterations, which typically include amplifications, partial tandem duplications (PTDs) and translocations (Rao et al. 2015). KMT2A alterations are observed in 5-20% of Acute Myeloid Leukemia (AML) cases, and are associated with poor outcome (Choi et al. 2018; Issa et al. 2021; Yuen et al. 2023). KMT2A PTDs (also known as MLL PTDs) are observed in 6-7% of Myelodysplastic Syndrome (MDS) as well, and alongside TP53 and FLT3 mutations are considered as top genetic predictors of adverse outcomes according to IPSS-M (Molecular International Prognostic Scoring System for Myelodysplastic Syndromes) (Bernard E et al. 2022; Choi et al. 2018). Accurate detection of KMT2A PTDs using next-generation sequencing (NGS) or fluorescence in situ hybridisation (FISH) approaches remains difficult (McKerrell et al. 2016; Afrin et al. 2018; Dai et al. 2021; Tsai et al. 2022), whereas MLPA technique was shown to yield robust and reliable results with a short turnaround time (Balgobind et al. 2010; Kentaro et al. 2013; ) allows more accurate detection of KMT2A PTDs when combined with DNA structural analysis approaches (Capo-Chichi et al. 2022).

ASXL1 is a gene that is frequently mutated in various haematological malignancies, including AML and MDS. The most common genetic alteration found in the ASXL1 gene is the c.1934dupG mutation, which leads to a premature stop codon in the ASXL1 transcript, resulting in a truncated ASXL1 protein which is rapidly degraded. Importantly, loss-of-function ASXL1 mutations were shown to promote myeloid transformation through loss of PRC2-mediated gene repression (Abdel-Wahab et al. 2012; Gelsi-Boyer et al. 2012). The ASXL1 c.1934dupG mutation appears to be mostly restricted to the haematopoietic lineage, and is associated with poor prognosis in AML and MDS patients (Gelsi-Boyer et al. 2012).

This SALSA MLPA probemix is not CE/FDA registered for use in diagnostic procedures. Purchase of this product includes a limited license for research purposes.

Probemix content
The SALSA MLPA Probemix P496-A1 KMT2A contains 60 MLPA probes with amplification products between 64 and 505 nucleotides (nt). This includes 17 probes for the KMT2A gene and two probes upstream and downstream of KMT2A gene, namely for the UBE4A and TMEM25 genes. This probemix also contains one probe specific for the ASXL1 c.1934dupG mutation which will only generate a signal when the mutation is present. Furthermore, probes were added for copy number determination of other regions commonly affected by CNAs in AML and MDS. These include two probes targeting CTNNA1 and NPM1 (5q deletions), one flanking probe for 5p, two probes for IKZF1, CUX1, KMT2E and EZH2 (chromosome 7 and 7q deletions); three probes for ATM (11q deletions), two flanking probes for the 11p arm, one flanking probe for 11q, three probes for TP53 (17p deletions), two probes for NF1 and one for SUZ12 (17q deletions). In addition, 13 reference probes are included that detect autosomal chromosomal locations and target relatively copy number stable regions in various cancer types including hematological cancers. Complete probe sequences and the identity of the genes detected by the reference probes are available online (

This probemix contains nine quality control fragments generating amplification products between 64 and 105 nt: four DNA Quantity fragments (Q-fragments), two DNA Denaturation fragments (D-fragments), one Benchmark fragment, and one chromosome X and one chromosome Y-specific fragment. More information on how to interpret observations on these control fragments can be found in the MLPA General Protocol and online at

SALSA Binning DNA SD096
The SD096 Binning DNA provided with this probemix can be used for binning of all probes including the mutation-specific probe (ASXL1 probe 18261-SP0848-L2626 for the c.1934dupG mutation). SD096 Binning DNA is a mixture of genomic DNA from healthy individuals and plasmid DNA that contains the target sequence detected by the above mentioned probe. Inclusion of one reaction with 5 μl SD096 Binning DNA in initial MLPA experiments is essential as it can be used to aid in data binning of the peak pattern using Coffalyser.Net software. Furthermore, Binning DNA should be included in the experiment whenever changes have been applied to the set-up of the capillary electrophoresis device (e.g. when capillaries have been renewed). Binning DNA should never be used as a reference sample in the MLPA data analysis, neither should it be used in quantification of mutation signal(s). It is strongly advised that all samples tested are extracted with the same method and derived from the same source of tissue. For further details, please consult the SD096 Binning DNA product description, available online: This product is for research use only (RUO).

Sample DNA
Sample DNA developed for this product:

Order Items


Item no.
SALSA MLPA Probemix P496 KMT2A – 25 rxn
€ 260.00
SALSA MLPA Probemix P496 KMT2A – 50 rxn
€ 510.00
SALSA MLPA Probemix P496 KMT2A – 100 rxn
€ 998.00

Required Reagents (Sold Separately)

Item no.
SALSA MLPA Reagent Kit – 100 rxn – FAM
€ 316.00
SALSA MLPA Reagent Kit – 100 rxn – Cy5
€ 316.00
SALSA MLPA Reagent Kit – 500 rxn – FAM
€ 1455.00
SALSA MLPA Reagent Kit – 500 rxn – Cy5
€ 1455.00
SALSA MLPA Reagent Kit – 2000 rxn – FAM
€ 5590.00

Related Products

SALSA MLPA Probemix P056 TP53

This probemix contains 15 probes for the detection of TP53 CNAs and TP53 flanking regions.


This probemix contains 21 probes for IKZF1 copy number determination.


This probemix contains eight probes targeting IKZF1.

SALSA MLPA Probemix P414 MDS

This probemix contains two probes targeting KMT2A, other probes targeting chromosomal arms 5q and 7q, and also includes several target for revised International Prognostic Scoring System (IPSS-R) for myelodysplastic syndromes (chromosomes 3, 8q, 12p, 19 and Y).

SALSA MLPA Probemix P437 Familial MDS-AML

This probes contains targeting various genes, such as GATA2, TERT and RUNX1, that have been described to be relevant in the context of familial MDS and AML.

Sign in

Don't have an account? Create one

Forgot password?

Select Your Country

Choose your country to see the products for your location

New Product

First released on Nov 14, 2023